Acinetobacter baumanii
Multiresistance per hospital
(resistance to ceftazidime, ciprofloxacin and
amikacin)
All clinical specimens
(January - June 2014)
| Hospital | Medical Wards |
Surgical Wards |
ICU |
||||||||
%aba/total isolates |
Isolates Tested |
%R |
%aba/total isolates |
Isolates Tested |
%R |
%aba/total isolates |
Isolates Tested |
%R |
|||
| GR005 | 3,6% |
12 |
100,0 |
1,1% |
2 |
12,9% |
26 |
100,0 |
|||
| GR007 | 5,4% |
4 |
5,4% |
13 |
84,6 |
||||||
| GR012 | 10,7% |
9 |
66,7 |
17,2% |
5 |
22,1% |
27 |
92,6 |
|||
| GR014 | 3,8% |
46 |
76,1 |
2,1% |
7 |
100,0 |
16,8% |
80 |
97,5 |
||
| GR018 | 2,2% |
8 |
50,0 |
1,9% |
4 |
20,8% |
25 |
80,0 |
|||
| GR026 | 1,4% |
4 |
0,5% |
1 |
16,2% |
11 |
100,0 |
||||
| GR030 | 5,4% |
20 |
80,0 |
8,2% |
7 |
85,7 |
16,1% |
19 |
94,7 |
||
| GR031 | 3,5% |
20 |
85,0 |
3,6% |
14 |
92,9 |
24,8% |
67 |
100,0 |
||
| GR032 | 3,7% |
9 |
100,0 |
2,9% |
2 |
17,7% |
21 |
100,0 |
|||
| GR037 | 5,8% |
10 |
50,0 |
14,1% |
4 |
18,8% |
7 |
85,7 |
|||
| GR039 | 5,1% |
23 |
87,0 |
7,4% |
22 |
68,2 |
14,5% |
24 |
95,8 |
||
| GR040 | 4,4% |
22 |
59,1 |
4,9% |
11 |
81,8 |
16,9% |
21 |
90,5 |
||
| GR041 | 5,0% |
41 |
75,6 |
4,0% |
11 |
63,6 |
22,2% |
31 |
90,3 |
||
| GR043 | 6,6% |
41 |
97,6 |
2,4% |
1 |
32,0% |
73 |
98,6 |
|||
| GR048 | 2,7% |
1 |
18,8% |
3 |
|||||||
| GR051 | 4,3% |
2 |
8,5% |
4 |
25,0% |
17 |
100,0 |
||||
| GR055 | 1,1% |
1 |
|||||||||
| GR068 | 3,6% |
8 |
50,0 |
6,5% |
50 |
68,0 |
19,6% |
51 |
70,6 |
||
| Weighted Average | 3,9% |
275 |
78,5 |
5,0% |
151 |
76,2 |
17,5% |
516 |
93,2 |
||
| Hospital Mean | 75,2 |
80,0 |
92,6 |
||||||||
